Assessment of the impact of weekly versus monthly erythropoiesis stimulating protein therapy on patients with CKD and their families.
Nephrol Nurs J
; 34(2): 151-61, 2007.
Article
en En
| MEDLINE
| ID: mdl-17486946
ABSTRACT
This cross-sectional study measured patient and family member reported treatment and economic burden associated with monthly versus weekly erythropoiesis stimulating protein therapies for anemia in patients with CKD who were not yet on dialysis. The results indicated that compared to a weekly regimen, a monthly regimen saved patients 7 hours and family members 19 hours per month for routine anemia management. The monthly regimen substantially reduced the reported economic and treatment burdens of patient and their family members.
Buscar en Google
Banco de datos:
MEDLINE
Asunto principal:
Familia
/
Eritropoyetina
/
Eritropoyesis
/
Anemia
/
Fallo Renal Crónico
Tipo de estudio:
Etiology_studies
/
Observational_studies
/
Qualitative_research
/
Risk_factors_studies
Límite:
Aged80
/
Female
/
Humans
/
Male
/
Middle aged
Idioma:
En
Revista:
Nephrol Nurs J
Asunto de la revista:
ENFERMAGEM
/
NEFROLOGIA
Año:
2007
Tipo del documento:
Article
País de afiliación:
Estados Unidos